FGEN (FibroGen Inc) Net Margin

Corporate company logo of FibroGen, Inc. (FGEN)

FibroGen, Inc. (FGEN) revenues are based on the recognition of its drugs against fibrosis and anemia. Net income per unit of sales demonstrates current resilience, where the 1970.00 metric indicates profitability status. Breakthrough erythropoiesis stimulation methods are opening new markets, although the company is currently undergoing rigorous cost optimization and seeking strategic partners to maintain liquidity.

FibroGen Corporation (FGEN) Net Margin: for the period 07/04/2022 - 01/08/2026

Analytical breakdowns for FibroGen, Inc.

- share price and expert price forecast:
Summary company analysis:FibroGen, FGEN
Flagship merchandise of FibroGen Corp

Professional asset selection begins with an analysis of profit resilience against operating expenses. This metric determines the share of net profit in total revenue, reflecting the ultimate efficiency of the business. The net profit margin dynamics on GURU.Markets allow for the identification of a company's systemic degradation or recovery. For FibroGen, Inc. (FGEN), this indicator is critical during the transition to strict resource austerity. Current asset restructuring and a focus on early-stage oncobiotech should stabilize this figure.

Who FibroGen, Inc. competes with

HLN: Net Sales Margin|Net Return on Sales KVUE|Net Margin veronapharma.com|Net Return on Sales MENS (Jyong Biotech Corp)|Net Margin Ligand (LGND)|Net Sales Margin amneal.com (AMRX)|Net Sales Margin PRGO (perrigo.com)|Alvotech SA (ALVO) - Net Margin|Liquidia Inc. - Net Sales Margin|Net Profitability Margin Galapagos Corp (GLPG)|ANI Pharmaceuticals (ANIP) - Net Margin|Net Return on Sales MNKD|Net Margin Amphastar Pharmaceuticals, Inc.|Pacira Pharmaceuticals (PCRX) - Company Sales Margin|Net Sales Margin SPRY|TBPH - Net Margin|Aquestive Pharma - Return on Sales by Net Profit|Net Sales Margin scpharmaceuticals.com SCPH|Tectonic - Net Sales Margin|TNXP - Net Sales Margin|SXTC: Net Sales Margin|Eupraxia Pharma - Net Profit Rate|BHST (bioharvest.com) - Net Sales Margin|Net Return on Sales EXOZ (invizyne.com)|Net Sales Margin ORMP|Company Sales Margin Entera Bio|Net Sales Margin HYFT (MindWalk Holdings, Inc.)|ABVC BioPharma - Net Margin|Cumberland Corp - Net Sales Margin|QNTM - Net Sales Margin|TELO (Telomir Pharmaceuticals) - Return on Sales by Net Profit|Rani Therapeutics Holdings - Net Profit Rate|Return on Sales by Net Profit SNYR|Net Margin rallybio.com RLYB|Net Sales Margin LEXX|PULM (Pulmatrix, Inc.) - Net Profit Rate|Pheton Holdings - Return on Sales by Net Profit|Net Sales Margin Aptorum Group Limited APM|LYRA: Return on Sales by Net Profit|IBO: Net Margin|TNFA: Net Sales Margin|YCBD: Company Net Profitability|Net Margin PainReform Ltd|CYTO (altamiratherapeutics.com) - Company Net Profitability|Net Sales Margin LIPO|OPTN - Net Margin|Net Margin pieris.com PIRS|Net Profit Rate PROC|PTPI - Net Margin|Qilian International Holding (QLI) - Return on Sales by Net Profit|SLRN: Net Sales Margin|Return on Sales by Net Profit TFF Pharma